IL6 and metabolic dysfunction-associated steatotic liver disease: Activation of Na/K-ATPase/ROS signaling may stimulate macrophages to produce higher levels of pro-inflammatory cytokines/chemokines (TNF-a, IL-18, IL-6, and MCP-1) that promote the development of NAFLD and NASH [139,141].